Icade receives EUR 14 sell target: Icade stock sits 33.39 percent below its high

Icade stock was trading at EUR 15.16 at Lang & Schwarz on October 2, 2026 at 12:43 p.m. CEST, 33.39 percent below its 52-week high of EUR 22.76. Icade received a EUR 14 sell target against EUR 19 previously in an October 2, 2026 market review from Ideal Investisseur.

Target cut meets weak valuation

The target reduction puts the analyst view below the Lang & Schwarz price, while the stock remains well below its 52-week high. The reference price was EUR 15.16 against a prior close of EUR 15.20, a decline of 0.26 percent.

The valuation debate follows a difficult first half. Ideal Investisseur reported first-half 2026 revenue of EUR 600.8 million, down 4.70 percent from the comparable period, and net income of negative EUR 155.9 million.

First-half guidance stays intact

Icade maintained its 2026 guidance for current net cash flow of EUR 2.90 to EUR 3.10 per share, according to Ideal Investisseur. The guidance range gives investors a concrete operating benchmark even as the reported loss weighs on the equity story.

The same first-half review cited a 3.10 percent decline in asset value on a constant perimeter basis and an average debt cost of 1.85 percent. Those figures show why the EUR 14 target is centered on balance-sheet and financing pressure rather than on development volume alone.

Emblème adds 177 homes

Icade's latest operating announcement concerns the Emblème program in Toulouse. The project combines 177 housing units with 3,000 square meters of offices in the La Cartoucherie Eco-district, as Ideal Investisseur reported on September 29, 2026.

The mixed complex covers 16,102 square meters, including 11,286 square meters of housing, and 149 units were sold in bulk to Promologis. That project mix supports Icade's development platform, but it does not remove the pressure reflected in the latest target revision.

Stock stays below its yearly high

Icade's market capitalization stood at EUR 1.1 billion as of October 2, 2026. The 52-week range was EUR 15.02 to EUR 22.76, leaving the Lang & Schwarz price 33.39 percent below the upper end.

The contrast is clear: operational projects continue to add housing and office capacity, while the first-half loss, lower asset values and higher debt costs shape the valuation discussion. For investors, the EUR 2.90 to EUR 3.10 current net cash flow range is the key test against the EUR 14 sell target.

Trading was at EUR 15.16 at Lang & Schwarz on October 2, 2026 at 12:43 p.m. CEST, down 0.26 percent versus the prior close of EUR 15.20 on October 1, 2026. The further course of trading is shown by the continuously updated real-time quote of Icade stock.

More news and analyses on Icade stock